- 英文名称
- Oxytocin acetate
- 分子式
- C45H70N12O14S2
- 分子量
- 1067.24
- 中文别名
- 醋酸缩宫素; (S)-N-((S)-1-((2-氨基-2-氧代乙基)氨基)-4-甲基-1-氧代戊烷-2-基)-1-((4R,7S,10S,13S,16S,19R)-19-氨基-7-(2-氨基-2-氧代乙基)-10-(3-氨基-3-氧代丙基)-13-((S)-仲丁基)-16-(4-氧基苯基)-6,9,12,15,18-五氧代-1,2-二硫杂-5,8,11,14,17-五氮杂环二十烷-4-羰基)吡咯烷-2-甲酰胺乙酸盐; Oxytocin Monoacetate; Orasthin Acetate; Perlacton Acetate; Pitocin Acetate; Synpitan Acetate; Syntocinon Acetate; Uteracon Acetate; Oxytocin (acetate); 1-{[(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-L-leucylglycinamide acetate (1:1); 1-{[(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-2-butanyl]-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-prolyl-L-leucylglycinamide acetate (1:1); Glycinamide, 1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-13-[(1S)-1-methylpropyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-yl]carbonyl]-L-prolyl-L-leucyl-, acetate (1:1) (salt); (S)-N-((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide acetate
- 用途
- 子宫收缩药;作为多效的下丘脑肽，有助于分娩、哺乳和亲社会行为；作为压力应对分子，具有抗炎、抗氧化剂和保护作用，特别是在面对逆境或创伤时；刺激乳腺分泌乳汁，在分娩过程中促进子宫平滑肌的收缩；减少人体内肾上腺酮等压力激素的水平，以降低血压
